tert-Butyl 2-(4-(pyridin-2-yl)benzyl)hydrazinecarboxylate CAS 198904-85-7 Atazanavir Intermediate

Short Description:

tert-Butyl 2-(4-(pyridin-2-yl)benzyl)hydrazinecarboxylate

CAS: 198904-85-7

Purity: ≥98.0%

Appearance: White to Light Yellow Powder

Intermediate of Atazanavir HIV Protease Inhibitor Antiviral

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com

Send email to us

Product Detail

Product Tags

Description:

Manufacturer Supply Atazanavir Related Intermediates
Moc-L-Tert-Leucine CAS 162537-11-3
4-(2-Pyridyl)benzaldehyde CAS 127406-56-8
(2S,3S)-1,2-Epoxy-3-(Boc-Amino)-4-Phenylbutane CAS 98737-29-2
(2R,3S)-1,2-Epoxy-3-(Boc-Amino)-4-Phenylbutane CAS 98760-08-8
tert-Butyl 2-(4-(pyridin-2-yl)benzyl)hydrazinecarboxylate CAS 198904-85-7
Atazanavir CAS 198904-31-3
Atazanavir Sulfate CAS 229975-97-7

Chemical Properties:

Chemical Name	tert-Butyl 2-(4-(pyridin-2-yl)benzyl)hydrazinecarboxylate
Synonyms	1-Boc-2-[4-(2-pyridinyl)benzylidene]hydrazine
CAS Number	198904-85-7
CAT Number	RF-PI381
Stock Status	In Stock, Production Scale Up to Hundreds of Kilograms
Molecular Formula	C17H21N3O2
Molecular Weight	299.37
Melting Point	74.0~77.0℃(lit.)
Density	1.117±0.06 g/cm3
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Appearance	White to Light Yellow Powder
Loss on Drying	≤0.50%
Purity	≥98.0%
Test Standard	Enterprise Standard
Usage	Intermediate of Atazanavir

Package & Storage:

Package: Bottle, Aluminium foil bag, Cardboard Drum, 25kg/Drum, or according to customer's requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture.

Advantages:

FAQ:

Application:

tert-Butyl 2-(4-(pyridin-2-yl)benzyl)hydrazinecarboxylate (CAS: 98904-85-7) is an intermediate generated during production of antiviral protease inhibitors. It's an intermediate of Atazanavir. Atazanavir is an inhibitor of HIV-1 protease (EC50=2.6 nM). In isolated cells, it has additive to moderately synergistic antiviral effects when combined with other antiretroviral drugs. As a result, it is commonly used in vivo in combination therapy for HIV-1 infection.